CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Alkaloid AD Skopje Company Snapshot
Alkaloid AD Skopje operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Alkaloid AD Skopje with three other pharmaceutical manufacturers in Europe: EastPharma Ltd of Turkey (2017 sales of 801.44 million Turkish Liras [US$171.65 million] of which 93% was Human Pharma), Eckert & Ziegler Strahlen- und Medizinte of Germany (138.63 million Euro [US$163.29 million] of which 62% was Isotope Products), and Deva Holding AS which is based in Turkey (800.30 million Turkish Liras [US$171.40 million] of which 93% was Pharmaceuticals).

Sales Analysis. Alkaloid AD Skopje reported sales of 9.09 billion Denar (US$173.98 million) for the year ending December of 2017. This represents an increase of 9.7% versus 2016, when the company's sales were 8.29 billion Denar. Sales at Alkaloid AD Skopje have increased during each of the previous five years (and since 2012, sales have increased a total of 34%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Alkaloid AD Skopje
  Stock Performance Chart for Alkaloid AD Skopje
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 8,100.00
(Figures in Denar)
1 Week 3.2%   13 Weeks 5.0%  
4 Weeks 1.3%   52 Weeks 38.5%  
 
Alkaloid AD Skopje Key Data:
  Ticker: ALK Country: Macedonia
  Exchanges: Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 9,094,716,000
(Year Ending Jan 2018).
Employees: 1,374
  Currency: Denar Market Cap: 11,474,557,200
  Fiscal Yr Ends: December Shares Outstanding: 1,416,612
  Share Type: Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.